IBSA USA’s Post

#DYK most prescriptions written to treat hypothyroidism are for levothyroxine tablets? Tirosint (levothyroxine sodium) capsules are unique gel capsules free of gluten, dyes, preservatives, or lactose. 🔹To learn how Tirosint is different, visit: https://lnkd.in/eHtPKrZa Tirosint® (levothyroxine sodium) capsules is L-thyroxine (T4) and indicated for use in adults and pediatric patients 6 years and older, with congenital or acquired hypothyroidism. Tirosint can also be used for Pituitary Thyrotropin (Thyroid Stimulating Hormone (TSH)) Suppression. Thyroid hormones, including Tirosint, should not be used for the treatment of obesity or for weight loss. Doses beyond the range of daily hormonal requirements may produce serious or even life-threatening manifestations of toxicity. Tirosint is not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients, or for the treatment of transient hypothyroidism during the recovery phase of subacute thyroiditis. Tirosint is contraindicated in patients with uncorrected adrenal insufficiency. For elderly patients and those with underlying cardiovascular conditions, starting with a lower dose is recommended due to the heightened risk of cardiac adverse reactions, including atrial fibrillation. Oral thyroid hormone drugs should not be used to treat myxedema coma, and replacement glucocorticoids are necessary for patients with concomitant adrenal insufficiency before initiating Tirosint. To prevent hyperthyroidism or for the incomplete treatment of hypothyroidism, proper dose titration and careful monitoring are essential. Diabetic patients should carefully monitor glycemic control after starting, changing, or discontinuing thyroid hormone therapy since glycemic control may worsen in diabetic patients. Decreased bone mineral density associated with thyroid hormone over-replacement may occur. Adverse reactions associated with Tirosint primarily reflect symptoms of hyperthyroidism due to overdosage including: arrhythmias, heart attack, dyspnea, muscle spasm, headache, nervousness, irritability, insomnia, tremors, muscle weakness, increased appetite, weight loss, diarrhea, heat intolerance, menstrual irregularities, and skin rash. Patients should ask their doctor if Tirosint is right for them. For more information and Full Prescribing Information including Boxed Warning and Important Safety Information, visit https://lnkd.in/e-SXTEje. #IBSA #CaringInnovation #IBSAUSA #WeareIBSA #Tirosint #hypothyroidism *This post intended for US audience only.

Thank you to all who stopped by IBSA USA's booth during the Pri-Med Midwest - Primary Care CME/CE Conference & Expo this week. Weston Reynolds and Keith Ciucci were on hand at our exhibit booth to share product information with healthcare practitioners and answer questions about IBSA USA's line of products. 🔹 To learn more about how IBSA's products can help enhance patient care, particularly for those managing conditions like hypothyroidism and acute pain, visit www.ibsapharma.com. #IBSA #CaringInnovation #WeareIBSA #IBSAUSA #primedmidwest #primarycare #endocrinology #acutepain

Congratulations to the high-performing members of IBSA USA's sales team who earned the prestigious 2023 Veloce Award! Winners were presented with the award during IBSA USA's National Sales Meeting in March. As part of their recognition, Jason Gamble, Lindsey Blair, PharmD, Josh Posner, Charlotte Donati, PACS, Danica C., Matt Allin, Nelson Henry, Charles Amerise, Maribeth Morrissey, Todd Weatherford, and Marie Lacombe enjoyed an unforgettable trip to IBSA's Global Headquarters in Lugano, Switzerland and as a team, visited beautiful sights in the surrounding area including Lake Garda and Verona. 🔹 To join our outstanding sales team, view IBSA USA's open positions here: https://lnkd.in/dunU9yBm #IBSA #CaringInnovation #IBSAUSA #WeareIBSA #sales #pharmasales Michael Scully, Bill Vavrik

IBSA Foundation for scientific research believes that research and education are key to building a better future. For this reason, it supports research, as well as the education of young generations, by offering male and female researchers under 40 annual fellowships in several fields of basic and clinical research. Furthermore, it supports students of the Faculty of Biomedical Sciences of the USI Università della Svizzera italiana (USI) with annual scholarships. 🔹Find out more about IBSA Foundation Fellowships: https://lnkd.in/ej6GprqW #IBSA #CaringInnovation #IBSAFoundation #CorporateSocialResponsibility IBSA Group

This week, members of IBSA USA’s marketing team attended Momentum Event’s 5th Promotional Review Summit in Philadelphia, PA. The regulatory landscape is constantly evolving, and attending educational programs is one way IBSA USA stays ahead of the latest requirements and industry guidelines. These events provide valuable insights that not only help us drive greater efficiency in our promotional review processes but also allow us to explore strategies for measuring effectiveness, streamlining workflows, and ensuring compliance. 🔹Stay up to date on IBSA USA’s exciting initiatives: https://lnkd.in/eiwnZBiX #IBSA #CaringInnovation #IBSAUSA

This weekend, IBSA USA is attending the 27th International Thyroid Cancer Survivors’ Conference in Houston, TX. The event brings together survivors, caregivers, and medical experts to provide the latest information on thyroid cancer treatment and patient care. Attendees will have the opportunity to have their questions answered, access up-to-date thyroid cancer materials, and connect with other survivors to support their thyroid cancer journey. 🔹 To learn more about IBSA USA and our products in endocrinology, visit: www.ibsapharma.com. #IBSA #CaringInnovation #IBSAUSA #ThyCa Duni Cummings-John, MD, Carolyn Kong, Jarrid Spiegel

Have you wondered what it's like to be part of IBSA USA? Head over to our Life page right here on LinkedIn to meet members of our dynamic team, learn about exciting initiatives, and get an inside look at what makes our workplace and culture one that we're proud of. On this page, you can also share your profile with our recruiters and discover how you can join our team. 🔷 Explore Life at IBSA USA: https://lnkd.in/eK8xnC65 #IBSA #CaringInnovation #IBSAUSA

Following a successful kickoff in Southlake, TX, IBSA USA continued our Plan of Action (POA) series in Morristown, NJ, bringing together teams from the Northeast, Mid-Atlantic, and Midwest regions. These meetings provide an opportunity to discuss business goals and review tactics to enhance performance and finish the year strong. A special thank you to all who participated in our POA meetings! 🔷 To become a part of IBSA USA's growing team, visit: https://lnkd.in/dunU9yBm   #IBSA #CaringInnovation #IBSAUSA #WeareIBSA #POAMeetings Komal Pnesar Christine McSorley Brandon O'Callahan Ariel Chi Sparkle Ivery Josh Posner Mark Oliver Bryan Kernaghan Taylor Pohleven Scottie Denis isabella jandreski Charles Fields Nick Soares David Mason Liam Kenney Nichole Rineer Lindsey Blair, PharmDCharlotte Donati, PACS Melissa Godlewski Marissa Trainor Todd Weatherford Jake Seaman Will Bellucci Tom Lien, RPh Meghan Hunter Jennifer Feeney kazi parvez Linda Smith Donald Leathers Melissa Pressler, MS, CHES, ACSM-CPT Brooke Willis David Rosolack, MBA Weston Reynolds Judy Laning Rochelle B. Jennifer Boldizsar

Following yesterday’s business review meeting in Parsippany, NJ, Luca Crippa, IBSA Corporate’s Chief Commercial Officer, and Michael Scully, Head of US Commercial at IBSA USA, took to the field for a ride-along with Philadelphia-area sales representatives Nichole Rineer and Meghan Hunter. Throughout today’s meetings with HCPs, the team shared information about innovative prescription products and the new additions to the IBSA Care line of dietary supplements. These field sales rides provide invaluable insights, helping IBSA USA stay connected with healthcare professionals and ensuring we consistently deliver value to patients. 🔹 Learn more about IBSA USA: www.ibsapharma.com #IBSA #CaringInnovation #WeareIBSA #IBSAUSA #pharmasales